Brief: 4Basebio Announces Key Milestone With Client Progressing Into Phase I Clinical Trials Of mRNA Vaccine

4Basebio

21/03/2024 07:43

March 21 (Reuters) - 4Basebio PLC  4BB.L :
    * 4BASEBIO PLC: 4BASEBIO CLIENT'S PHASE I CLINICAL TRIALS
FOR OPDNA™ BASED MRNA VACCINE
    * 4BASEBIO PLC - ANNOUNCES KEY MILESTONE WITH ITS CLIENT
PROGRESSING INTO PHASE I CLINICAL TRIALS OF AN MRNA VACCINE
MANUFACTURED FROM 4BASEBIO'S OPDNA

Source text for Eikon:  ID:nPRrL9275a 
Further company coverage:  4BB.L 

 ((Reuters.Briefs@thomsonreuters.com;))